Journal article icon

Journal article

Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen.

Abstract:

BACKGROUND: The current study was conducted to assess the toxicity of concurrent adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy and radiotherapy (RT) for early breast carcinoma. METHODS: In the current study, the authors reviewed the records of 680 consecutive breast carcinoma patients who received adjuvant CMF at the Princess Margaret Hospital between 1980-1990. Surgery was comprised of mastectomy in 64% of patients, breast conservation in 35% of patients, an...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1002/cncr.10744

Authors


Panzarella, T More by this author
Kirkbride, P More by this author
Expand authors...
Journal:
Cancer
Volume:
95
Issue:
4
Pages:
696-703
Publication date:
2002-08-05
DOI:
EISSN:
1097-0142
ISSN:
0008-543X
URN:
uuid:0a417e62-aff1-4c3f-91db-bfc8c2079a5f
Source identifiers:
131369
Local pid:
pubs:131369

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP